Product Details

Voriconazole for Injection BP is manufactured to strict BP-standard specifications for use in the treatment of serious systemic fungal infections. It is prescribed for patients requiring hospital-based antifungal therapy.

The injection combines:

• Voriconazole — a triazole antifungal agent that inhibits fungal cytochrome P450-dependent synthesis of ergosterol, disrupting the fungal cell membrane and inhibiting fungal growth

Voriconazole for Injection BP is indicated in the treatment of invasive aspergillosis, candidemia, and serious fungal infections caused by Scedosporium and Fusarium species. As a result, it is administered under medical supervision, typically in hospital wards and intensive care settings.

Key Features:

• Manufactured to BP-standard compliance for consistent quality
• Lyophilized sterile powder ensures stability before reconstitution
• Accurate potency per vial supports precise dosing in antifungal therapy
• Supplied with Sterile Water for Injection BP for convenient reconstitution
• Single Dose Vial format minimizes contamination risk
• Suitable for hospital pharmacies and institutional supply